TRxADE HEALTH, INC. to Report Fourth Quarter and Year End 2021 Financial Results on Monday, March 28th at 5:00 p.m. Eastern Time

Rhea-AI Summary

TRxADE HEALTH INC. (NASDAQ: MEDS) will announce its fourth quarter and year-end 2021 financial results on March 28, 2022, after market close. A conference call is scheduled for 5:00 p.m. Eastern time on the same day to discuss these results, including a Q&A session. The company, which focuses on optimizing the retail pharmacy experience in the U.S., operates the TRxADE drug procurement marketplace, serving over 12,700 members. Details for dial-in and webcasting will be provided for interested participants.

Positive

• Company operates the TRxADE drug procurement marketplace serving over 12,700 members.
• Focus on digitalizing the retail pharmacy experience highlights innovation.

Negative

• None.

TAMPA, FL / ACCESSWIRE / March 14, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the fourth quarter and Year End 2021, after market close on March 28, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.

In addition, management will host a conference call on Monday, March 28, 2022, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH's fourth quarter and year end 2021 financial results. The call will conclude with a Q&A from participants. To participate, please use the following information:

Q4 2021 Conference Call and Webcast
Date: Monday, March 28, 2022
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13727651
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1534472&tp_key=20fddfb1b1

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

A playback of the call will be available through April 28, 2022. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13727651. A webcast will also be available for 30 days on the IR section of the Trxade Group website or by clicking the webcast link above.

About TRxADE HEALTH, INC.
TRxADE HEALTH (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,700+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE HEALTH, please visit the Company's IR website at investors.trxadegroup.com.

Investor Relations:
IR@trxade.com
Investors.trxadegroup.com

SOURCE: TRxADE HEALTH, Inc.

View source version on accesswire.com:
https://www.accesswire.com/692827/TRxADE-HEALTH-INC-to-Report-Fourth-Quarter-and-Year-End-2021-Financial-Results-on-Monday-March-28th-at-500-pm-Eastern-Time

FAQ

When will TRxADE HEALTH report its financial results for Q4 2021?

TRxADE HEALTH will report its financial results for the fourth quarter and year-end 2021 on March 28, 2022, after market close.

What time is the TRxADE HEALTH conference call?

The conference call for TRxADE HEALTH will be held on March 28, 2022, at 5:00 p.m. Eastern time.

How can I participate in TRxADE HEALTH's conference call?

To participate in TRxADE HEALTH's conference call, dial 1-877-425-9470 for U.S. or 1-201-389-0878 for international calls, and use conference ID 13727651.

What does TRxADE HEALTH focus on?

TRxADE HEALTH focuses on digitalizing the retail pharmacy experience by optimizing drug procurement and enhancing patient engagement.